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FACIAL MICROBIOTA AND ANTIBIOTIC RESISTANCE: A COMPARATIVE 
STUDY OBSERVING THE PRESENCE OF RESISTANCE GENES AND 
DIMINISHED SUSCEPTIBILITY 
 
 
An Abstract of the Thesis by  
Kayla Stricklan 
 
 
 The looming threat of increased antibiotic resistance leading to a post-
antibiotic world is progressively becoming a reality. A significant portion of the 
fight against antibiotic resistance development is slowing down the prescribing of 
antibiotics for unnecessary conditions while simultaneously encouraging stricter 
adherence to antibiotic course completion. One of the often-unnecessary 
conditions is acne vulgaris. Though the disease may be unsightly and 
discouraging, it does little to affect overall health of the individual with the 
exception of psychosocial affects. Utilizing facial swabs from 144 participants, 
samples were tested for the colonization of Propionibacterium acnes, 
Staphylococcus aureus and Staphylococcus epidermidis as well as the presence 
of resistance genes Cerm(X) and Tet(M) using polymerase chain reaction and 
gel electrophoresis. Amplification of the samples portrayed that 
Propionibacterium acnes was the most prevalent microbe present, even from 
samples obtained from students with minimal blemishes. The second most 
common was Staphyloccocus epidermidis and few samples tested positive for 
Staphylococcus aureus. Amplification of resistance genes demonstrated fair 
amounts of resistance present, even in participants who had not taken antibiotics 
in the last two years. Out of the 144 initial samples, 60 isolated samples were 
utilized for susceptibility testing and the first set determined a slight decrease in 
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diameter of the resulting zone of inhibition when exposed to clindamycin, 
doxycycline and tetracycline, but not rifampin.  
 A subsequent 42 samples were collected for susceptibility testing using 
direct colony suspension. Results from testing demonstrated a significant 
decrease in the zones of inhibition between those who had not taken antibiotics 
and those who had taken two types of antibiotics for general illnesses and acne. 
The differences between tetracycline, clindamycin, rifampin and doxycycline 
were 4.64, 6.34, 11.86 and 7.66-millimeters, respectively with significant p-values 
between rifampin and doxycycline suggesting that the development of resistance 
is more prevalent in rifampin than previously determined. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
Antibiotic Resistance: A Global Problem 
 
 Antibiotic use is on a continuous rise while the development of new 
antibiotics has reached a drastic halt. Combine both phenomenon with bacteria 
that are perpetually evolving and the world is facing a global crisis. Antibiotics 
have been likened to a four-edged sword against bacteria because they are 
capable of benefitting both the individual and the community by preventing the 
spread of illness but these benefits come at the cost of communal antibiotic 
resistance development and the collateral damage affecting one’s microbiota 
(Yatsunenko et al. 2012). Although antibiotics have existed in nature for 
hundreds of millions of years, they have become a cornerstone of medicine in the 
decades since the Second World War (Davies, 2010). It is widely known that 
Alexander Fleming ignited the search for competing antibiotics with his discovery 
of penicillin in 1928. Since then, the magnitude at which antibiotics are both 
prescribed and utilized has exploded and may be attributed to the perception that 
antibiotics are entirely safe (Blaser, 2016).  However, looking specifically at 
agriculture, evidence suggests that the use of small doses of antibiotics promotes 
growth in livestock and affects metabolic development (Zimmerman, 1986). 
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Further research has demonstrated an increase in a wide-array of comorbidities 
caused by antibiotic use including but not limited to obesity, diabetes, celiac 
disease and asthma. In mice, antibiotic exposure led to effects in adiposity and 
bone growth as well as altered normal immunologic development (Cho et al., 
2012).  Aside from these, the biggest side effect of antibiotic use is the potential 
for development of antibiotic resistance, which is often overlooked and demands 
more attention.  Antibiotics are incredibly vital and should not be completely 
avoided. It is imperative that more accurate antibiotics be developed for targeting 
individual pathogens to minimize damage and preserve communal structure and 
function in the healthy microbiome rather than bombarding and forcing germs 
into submission with broad-spectrum antibiotics (Blaser, 2016).  
 The development of resistance is evolutionary and inevitable even when 
used properly (O’Neil, 2014).  An integral problem with antibiotic use is the 
misuse and abuse when both consuming and prescribing them. Controlling the 
excesses may stabilize the situation but cannot reverse the deterioration that has 
likely occurred (Clemente et al., 2015). Globally, consumption of antibiotics in 
human medicine had increased by nearly 40 percent between 2000 and 2010. 
The most recent estimates suggest that deaths attributed to antimicrobial 
resistance may rise from the current estimate of 700,000 lives per year to ten 
million lives annually by 2050 (O’Neill, 2014).  Because antibiotics are a mainstay 
in medicine, a world without their effectiveness would be dismal at best. Just 
about every ailment would be affected ranging from more severe medical 
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necessities like surgery and cancer treatment using chemotherapy to typical, 
less-severe and more widespread issues like acne vulgaris.   
 
Propionibacterium acnes: History and Microbiological Implications 
  The “bacillus of acne” that is currently known as Propionibacterium has 
not always been classified under the genus. Unna discovered P. acnes in 1896 
while researching blackheads. In 1923, the bacterium was mistakenly placed 
under the genus Corynebacterium. Although the two are closely related, they 
differ in catabolic processes and tolerance of oxygen. Ten years later, the 
bacterium was correctly classified (Douglas & Gunter, 1946). The genus 
Propionibacterium is named for the ability of some of its species to synthesize 
propionic acid, making them useful in the production of various compounds in the 
industrial manufacturing of probiotics and cheese (Falentin et al., 2010). 
Commonly a gram-positive anaerobic bacillus residing in the sebaceous follicles 
of the human skin, P. acnes has also been found in the oral cavity, intestinal 
tract, and the external auditory canal (Grice & Segre, 2011). When discovered in 
these locations, the bacteria are commensal, but the microorganism has been 
blamed for opportunistic infections in cerebrospinal fluid shunts, breast implants, 
cardiovascular devices and prosthetics (Piper et al., 2009).  
 Propionibacterium acnes is an aerotolerant organism, found to be able to 
tolerate oxygen for a few hours. If allowed to grow anaerobically, P. acnes will 
survive for up to eight months in vitro and can survive for extended periods of 
time in human tissues that have low oxidation potentials (Csukas, Banizs and 
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Rozgonyi, 2004). The microbes are slow-growing, usually requiring 7-14 days of 
incubation. They can also resist phagocytosis and have the ability to persist in 
macrophages (Webster et al., 1985). Its ability to survive for extended periods of 
time may be attributed to its capacity to produce biofilms, a thin and slimy film of 
bacteria that adheres to the surface of the organism, conferring protection. To 
characterize P. acnes, biochemical tests, as well as susceptibility tests, are 
recommended. The bacterium is catalase positive, nitrate reductase positive and 
indole positive in 70 percent of samples. It is resistant to metronidazole and 
fosfomycin (Aubin et al., 2014). 
 
Acne and Antibiotic Resistance Development  
 While there are much more severe conditions that require antibiotic 
intervention, one of the most common diseases requiring treatment is acne 
vulgaris, a skin disease affecting up to 50 million individuals in the United States 
(Zeichner, 2013). The highest prevalence of the disease can be found in people 
between the ages of 12 and 24 with approximately 85% of the population 
affected (Harrop et al., 2007). Acne vulgaris will manifest in a variety of ways with 
the initial lesions presenting as open and closed comedones, commonly referred 
to as blackheads and whiteheads, respectively. The open comedo is exposed to 
the skin's surface and exposed to oxidation which converts the sebum to a 
grayish or black color (Fife, 2009). Closed comedones, on the other hand, are 
composed of a collection of sebum, keratinocytes, and microorganisms 
responsible for blocking the follicular opening. While comedones are considered 
  5 
non-inflammatory, other lesions typical of acne vulgaris are inflammatory. These 
lesions are commonly referred to as pustules, papules, nodules or cysts. Patients 
with a few comedones are considered to have mild acne while those with many 
comedones are deemed as moderate. These types of patients are typically able 
to treat their lesions with topical retinoids. Severe patients have acne that 
presents as both inflammatory and non-inflammatory lesions. It is in the 
moderate-severe range that patients should seek antibiotic medication. Further 
issues arise when patients use topical or systemic antibiotics alone as 
monotherapy significantly increases the development of antibiotic resistance 
(Fife, 2009). The addition of benzoyl peroxide in combination with oral or topical 
antibiotics significantly reduces antibiotic resistance development because it acts 
to wash out the colonizing, resistant bacteria (Gollnick et al., 2003).  
 The skin is the largest human organ and is composed of many types of 
commensal bacteria. Two of the most predominant species found colonizing the 
skins surface are Propionibacterium acnes and Staphylococcus epidermidis, 
followed by the presence of Staphylococcus aureus, Micrococci, 
Corynebacterium spp. and several other genera.  Propionibacterium colonizes 
the lipid-rich pilosebaceous skin follicles and are thought to be the primary cause 
behind the development of the multifactorial disease acne vulgaris. The disease 
is multifactorial because all factors including increased sebum, ductal epidermal 
hyperproliferation, colonization of P. acnes and inflammation contribute to 
disease (Harper and Thiboutot, 2003). Although the species is considered 
commensal with potential for health-beneficial side effects, there is much 
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evidence to suggest that P. acnes acts as an opportunistic pathogen as well 
(Perry & Lambert, 2011).  The production of chemotactic factors and 
proinflammatory interleukins like IL-2 are mainly responsible for the inflammatory 
phase of acne vulgaris. Interleukin-2 acts as a pro-inflammatory mediator, 
recruiting T lymphocytes, neutrophils and foreign body giant cells (Leyden, Del 
Rosso and Webster, 2007). Propionibacterium acne possesses the ability to 
metabolize sebaceous triglycerides into fatty acids, which also attracts 
neutrophils and activates complement (Webster, 2002).    
 
Antibiotic Resistance Mechanisms in Microorganisms 
 Although the topic of antibiotic resistance is an ancient one as evidenced 
by the emergence of the serine beta-lactamases over two million years ago, it 
carries much more weight in today’s society (Hall & Barlow, 2004). The 
development of resistance in microorganisms can occur in an innumerable 
amount of ways. A population of bacteria may become resistant once they 
accumulate several mutations or by the acquisition of specific point mutations. 
They may also acquire resistance genes that protect the cell from antibiotic 
destruction. This resistance can be developed by genetic elements like 
transposons and plasmids that have the potential to transfer from strain to strain 
within the resident skin flora (Swanson, 2003). Plasmids act as platforms for the 
exchange of genes, allowing for reassembly and assortment, which gives 
bacteria the ability to collect potentially useful genes that enable them to expand 
into regions that were previously too hazardous for them (Bennett, 2008). 
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Transposons are systems of mostly random jumping genes that have the ability 
to incorporate resistance genes within their element either intramolecularly or 
intermolecularly, possibly moving from a plasmid to a bacterial chromosome and 
vice versa (Craig, 1997). 
  Bacterial resistance can be conferred actively in intricate manners, 
specific to the antibiotic target. A particular enzymatic strategy employed by 
bacteria in response to antibiotic pressure is hydrolysis. During hydrolysis, 
enzymes cleave vulnerable bonds crucial to their biological activity and in doing 
so; destroy their integrity (Wright, 2005). Phenotypic resistance can be caused by 
the enzymatic activation of an antibiotic, which then modifies the antibiotic target 
and prevents the accumulation of intracellular concentrations becoming large 
enough to kill the cell by way of efflux pumps (Allen, 2010). 
 
Acne Specific Antibiotics and Resistance Development 
 
 Acne vulgaris often requires antibiotic intervention. Though, not a fatal 
disease demanding emergency attention, the appearance of acne has been 
associated with significant psychosocial burdens, which greatly affect the quality 
of life in a negative manner (Tan, 2004). In fact, several studies have equated the 
battle with acne to have an emotional impact similar to disabling diseases like 
diabetes and epilepsy (Knutsen-Larsen et al., 2012). Because of this, acne is the 
most common disorder treated in dermatology practice, accounting for 8-9 million 
oral antibiotic prescriptions alone in the United States. The majority of which are 
broad-spectrum tetracycline derivatives, specifically doxycycline because of its 
ease of absorption and long half-life (Del Rosso, 2007). Other antibiotics that 
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have been used include macrolides like clindamycin and erythromycin, 
trimethoprim/sulfamethoxazole, benzoyl peroxide as a combination and topical 
antimicrobial as well as the recently emerging rifampin. These lipophilic 
antibiotics are the preferred drug of choice because although P. acnes 
demonstrates susceptibility to a wide array of antibiotics in vitro, in vivo they are 
the only drugs able to penetrate the lipid-filled microcomedones (Leyden, 2001).  
  Both oral tetracycline and erythromycin were available for treatment in the 
early 1950s, closely followed by doxycycline in 1967 and minocycline in 1972 
(Leyden, 2004). Early research in favor of the development of antibiotic 
resistance actually proved to be null and void. The first evidence of antibiotic 
resistance in vitro and in vivo to both erythromycin and clindamycin was 
discovered shortly after the introduction of topical agents, in 1979 (Crawford et al, 
1979). Though the study only included 22 patients, a demonstration of antibiotic 
resistance in twenty percent could not be ignored. Adding to this research in 
1983, Leyden and his colleagues proved that prevalence of antibiotic resistance 
was commonplace among those receiving long-term treatments of both 
tetracycline and erythromycin (Leyden, 1983). Additionally, in the late 1980-early 
1990s, an extensive study at Leeds discovered more clinically significant 
antibiotic resistance as well as strains of bacteria that were resistant to multiple 
drugs (Eady et al., 1993). A link between topical antibiotics and the development 
of antibiotic resistance has yet to prove that they are the integral cause of 
increased prevalence though several studies have nodded to the theory. A ten-
year study from 1992-2001 in particular observed the prevalence of resistance to 
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erythromycin and clindamycin in comparison to resistance caused by 
tetracycline. Resistance to erythromycin and clindamycin was more prevalent, 
demonstrating a possible link between topical agents and increased development 
of resistance (Coates et al., 2002).  
  A current estimate from data collected from five continents demonstrates a 
widespread and disturbing epidemic of P. acnes cases showing resistance to 
treatment with antibiotics (Dreno et al., 2014). A multitude of studies suggest the 
development of antibiotic resistance occurs in as many as 50 percent of cases 
following treatment with oral or topical antibiotics (Esperson, 1998). A positive 
relationship exists between antibiotic resistance development and lengthier 
treatment plans (Tan et al., 2001).  The use of antibiotics for long-term periods is 
to blame for selective pressures whereby antibiotics eliminate the susceptible 
bacteria while the antibiotic-resistant bacteria is left behind to continue 
proliferation (Patel et al., 2010). While some treatment plans suggest that a 6 to 
8-weeks course of antibiotics is perfect, other sources indicate that a patient 
must be treated for six months to avoid the establishment of antibiotic resistance. 
(Mills, Thornsberry et al. 2003). Further research details that P. acnes is not 
treated as a pathogen in the healthy individual and that resistant strains do not 
place them nor their contacts at severe risk for difficult to treat, systemic P. acnes 
infections. The problem lies within the commensals carried by humans that have 
the potential to become pathogenic as they can develop resistance to the 
antibiotics used in acne treatment (Patel, 2010). Antibiotic use in acne treatment 
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can also negatively impact the normal, protective flora found on the skin 
predisposing the body to colonization by opportunistic pathogens.  
  Both doxycycline and tetracycline are first choice antibiotics in the battle 
against acne vulgaris though doxycycline is preferred because it has proven to 
be more effective with an earlier clinical response (Leydon, 2009). Tetracyclines 
act by binding reversibly to the 30S ribosomal subunit and interfering with the 
binding of the tRNA-amino acid complexes, ultimately inhibiting protein synthesis 
(Bailey et al., 2014). Mutations in the gene encoding 16S rRNA have also been 
implicated as another cause of resistance development (Eady, Gloor and 
Leyden, 2003). Tetracyclines are considered broad-spectrum because they are 
effective against gram positive and negative bacteria as well as several 
intracellular pathogens and some protozoa. Resistance is conferred when there 
is a decreased penetration of the antibiotic into the bacterial cell. Efflux systems 
activate and flush antibiotics out of the cell, preventing accumulation. Protection 
of the bacterial 30S ribosomal subunit against antibiotic binding is often 
accomplished by the tet(M) gene (Corso et al., 1998). Tet(M) resistance is often 
achieved by way of transposons (Doherty et al., 2000). Other mechanisms of 
resistance include altering the ribosomal target site and enzymatic modification of 
the antibiotic (Mayers, 2009).  
 Thought to be a secondary line of treatment behind tetracycline, 
macrolides are a family of antibiotics that inhibit protein synthesis by preventing 
polypeptide elongation. In order to be effective, macrolides bind reversibly to the 
23S ribosomal RNA found on the 50S ribosomal subunit (Murray et al., 2016). 
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Resistance to erythromycin occurs once methylation of 23S rRNA takes place. 
This methylation prevents initial binding of the antibiotic, therefore hindering its 
efficacy. Alternative methods of resistance are conferred by enzymatic 
inactivation of the macrolide as well as point mutations encoding the V domain of 
the peptidyl transferase loop of 23S rRNA and ribosomal proteins (Ross et al., 
1997). Often times, target site alteration is encoded by the erm(X) gene (Ross et 
al., 2003). Point mutations occurring at site E. coli equivalent nucleotide base 
2058 in P. acnes confers cross-resistance to both erythromycin and clindamycin 
(Coates et al., 2002). Many studies have already emerged demonstrating the 
evidence of high levels of antibiotic resistance found in macrolides. This 
phenomenon can be attributed to the long-term treatments that are often required 
in acne therapy (Ross, 2001).  Another disturbing phenomenon surrounding 
macrolide resistance is the cross-resistance between them and lincosamides as 
well as streptogramins due to similar binding sites in rRNA shared by the three 
classes of antibiotics (Fan et al., 2016).  
 Erythromycin resistance in P. acnes has been observed as early as 1989 
when erythromycin-resistant Propionibacteria were isolated from skin surfaces of 
51 percent of patients treated with oral erythromycin. Those treated with topical 
clindamycin demonstrated resistance at a rate of 42 percent while only three 
percent of those who were untreated displayed resistance (Eady et al., 1989). A 
double-blind study performed in 2003 enrolled 208 patients with acne vulgaris in 
a 24-week study to determine resistance rates associated with the use of topical 
two-percent erythromycin gel. Eighty-seven percent of Staphylococci samples 
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taken initially showed erythromycin resistance, which increased to 98 percent 
after 12 weeks, with no sign of regression twelve weeks post treatment (Mills et 
al., 2003). A study recently published in 2014 employing the use of multilocus 
sequence typing (MLST) deduced that antibiotic resistance to macrolide-
lincosamide family of antibiotics was detected almost entirely throughout the 
sample of 76 patients. This resistance was attributed to the presence of point 
mutations found in 23S rRNA (Giannopoulos et al., 2014). An even more recent 
study performed in China, published in 2016, found combined resistance rates 
between macrolides and lincomycin to be extremely high at 47.8 percent (Fan et 
al., 2016). A study performed in vitro, examined samples from healthy skin and 
nodulocystic and pustular lesions taken from 100 patients, ranging from 18 to 24 
years of age. This study revealed that Propionibacterium acnes was at least 50% 
resistant to both clindamycin and erythromycin.  The study also demonstrated 
that rifampin was more inhibitory than any of the other antibiotics, including the 
combined effects of clindamycin and erythromycin with benzoyl peroxide 
(Hassanzadeh, Bahmani & Mehrabini, 2008). 
 Perhaps a newer emerging route of antibiotic treatment for acne is 
rifampin; a drug that prevents transcription by binding to DNA-dependent RNA 
polymerase and ultimately inhibiting nucleic acid synthesis (Murray et al., 2016). 
This antibiotic is considered a “gold standard” in the treatment against P. acnes 
because of its effectiveness against biofilm formations (Furustrand, Trampuz, 
and Corvec, 2013). Combining rifampin with another antibiotic has previously 
been thought to delay the development of antibiotic resistance. Unfortunately, 
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rifampin resistance is on a continual rise. In gram-positive bacteria, resistance is 
caused by a mutation in the chromosomal gene that codes for the beta subunit of 
RNA polymerase. This mutation, which takes place in the rpoB gene, reduces the 
ability of the antibiotic to bind to the enzyme (Furustrand, Corvec, and Betrisey, 
2012). Gram-negative bacteria are intrinsically resistant due to decreased uptake 
(Murray et al., 2016). Rifampin has demonstrated an ability to decimate the 
production of biofilm in P. acnes, both in vitro and in vivo (Bayston et al., 2007; 
Furustrand et al., 2012). A study performed in 2013 described the substitutions 
that conferred rifampin resistance in P. acnes. Progressive exposure to rifampin 
produced a double-mutation, and ultimately, rifampin resistance emerged rapidly 
without combination therapy (Tafin et al., 2013). 
 
Staphylococcus aureus and Staphylococcus epidermidis 
 The skin is not only colonized by P. acnes which begs the question, are 
other commensal microorganisms playing a role in pathogenesis? It has already 
been established that both P. acnes and S. epidermidis coexist along with other 
microflora within acne manifestations (Nishijima et al., 2000). But, recent 
estimates suggest that one-third to one-half of the general population with acne 
vulgaris are likely also to be colonized by Staphylococcus aureus, a gram-
positive coccus residing on the skin (Fanneli et al., 2011).  Described as one of 
the most common nosocomial pathogens, the bacterium is also ubiquitous and 
omnipresent. Staphylococcus aureus colonizes forty-fifty percent of the 
population as a whole, and the bacteria has a high ability to adapt and become 
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resistant, leading to the increasingly common methicillin-resistant 
Staphylococcus aureus (MRSA) infection, which can already be found in 
approximately five percent of the community (Deleo et al., 2010). In fact, the 
development of MRSA in patients is a serious problem. In 2007, the Centers for 
Disease Control and Prevention (CDC) estimated an overall incidence of 
approximately 65,000 cases of invasive MRSA with about 15,000 classified as 
community-acquired (Klevins et al., 2007). These staggering statistics leave 
much concern regarding the development of resistance in both S. aureus and P. 
acnes (Delost et al., 2015). Though there is significant in vitro evidence implying 
that Staphylococcus aureus is a pathogenic contributor to acne vulgaris, there is 
also contradicting evidence to support Staphylococcus epidermidis 
(Hassanzadeh, Bahmani, and Mehrabani, 2008). In this study, significantly higher 
percentages of S. aureus were observed in the normal skin of both girls and boys 
compared to P. acnes. Aerobically, Staphylococcus epidermidis was isolated 
from 53 percent of the 100 samples, followed by Micrococcus at 45 percent and 
S. aureus at 41 percent. Anaerobically, S. aureus was isolated the most from 39 
percent of the samples, followed by P. acnes at 33 percent and S. epidermidis 
from 21 percent (Hassenzadah, Bahmani, and Mehrabani, 2008). Further 
research suggests that prolonged use of antibiotics actually decimates the 
resident colonization of S. aureus (Delost et al., 2015).   
  Perhaps the most predominant pair colonizing the skin is P. acne and S. 
epidermidis. Because the two live in incredibly close proximity, their interaction 
has the potential to disrupt the delicate balance of the skin’s ecosystem 
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(Christensen et al., 2016). The possible disruption can contribute to the 
development of acne vulgaris (van Rensburg et al., 2015). While P. acnes 
exhibits a limited amount of strain variations but are still considered multiphyletic,  
S. epidermidis strains are even more heterogeneous than that. A study 
performed in 2016 compared the antagonism portrayed between the various 
strains found in both genuses on persons with acne-infected skin and those with 
healthier skin. The study found that two phylogroups of P. acnes increased 
antimicrobial activity against S. epidermidis while eleven out of 20 strains of S. 
epidermidis demonstrated the similar effects toward P. acnes (Christensen et al., 
2016). Both observations are examples of interspecies competition suggesting 
that S. epidermidis may be utilized in the war on acne because of its evident anti-
P.acnes activity.  
 
Proposed Thesis Project 
 The purpose of this research was to initially isolate and identify the most 
common genuses of bacteria colonizing the face using standard polymerase 
chain reaction and primers specified for each of the following bacteria: 
Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus 
epidermidis. Results suggest whether the prevalence of Staphylococcus aureus 
or Staphylococcus epidermidis or a mixture of the two in combination with P. 
acnes play a role in pathogenesis. Then, resistance genes commonly found 
among those bacteria who become resistant after interacting with antibiotics that 
are often used to treat acne vulgaris will also be used in polymerase chain 
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reactions to determine the amount of resistance in those who have and have not 
taken antibiotics. Selected resistance genes were Cerm(X) and tet(M). In 
addition, this research utilized commonly prescribed antibiotics like doxycycline, 
clindamycin and tetracycline and compares their efficacy against the 
effectiveness of rifampin, utilizing Mueller-Hinton agar and the Kirby-Bauer 
method. Susceptibility to each antibiotic was recorded to determine the amount 
of resistance present in specific samples from each population, to determine if 
increased antibiotic use leads to a decrease in the diameter of the resulting zone 
of inhibition. Samples were also gram-stained to confirm morphology of the 
colonies isolated from participants in order to more accurately determine 
susceptibility. By separating participants in to three separate categories (Table 
1), we may be able to observe whether antibiotic resistance is a direct cause of 
consumption or if resistance genes have been shared communally between the 
varying groups including those who have taken antibiotics specifically for acne in 
comparison to those who have taken antibiotics within the last two years for other 
illnesses vs. those who have not taken any antibiotics in the past two years. 
Number of 
Students 
Category 
46 0-Students who have taken no antibiotics in the last two years  
97 1-Students who have taken antibiotics for general reasons in 
last 2 years  
8 2-Students who have taken antibiotics only for acne 
35 3-Students who have taken antibiotics for both acne and general 
reasons 
Table 1. Division of Participants. Participants were divided into groups based 
on use of antibiotics.   
 
 
 
  17 
 
 
 
 
 
 
 
CHAPTER II 
 
 
MATERIALS AND METHODS 
 
 
Sample Collection 
 Samples were collected from 186 students attending Pittsburg State 
University in accordance with the standards and approval guidelines set forth by 
the Institutional Review Board (IRB). Prior to sampling, participants filled out a 
questionnaire detailing their history of antibiotic use for general illnesses as well 
as antibiotics taken specifically for acne, if applicable. Once applications were 
completed, 144 of the students’ samples were collected using sterilized cotton 
swabs and distilled water. Three cotton swabs were used for each participant. 
Each of the cotton swabs were dipped into distilled water and used to swab 
problem areas of the face on each participant. A majority of the swabs were 
taken from the forehead along the hairline, the crevices surrounding the nares, 
and the chin. Once the cotton swabs were inoculated with the bacterial sample, 
two were placed directly onto reinforced clostridial media (RCM). The third was 
placed into 200 microliters of phosphate buffered saline or PBS buffer and placed 
in the freezer at -10 degrees Celsius. RCM plates were then placed in the 
incubator for 5-7 days under anaerobic conditions, using an Anaeropack System, 
2.5-liter rectangular jar paired with a compatible satchet anaerobic gas 
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generating system. After seven days of growth, samples were removed from the 
anaerobic jar and semi-pure colonies were utilized for isolation streaking and 
allowed to grow for an additional 5-7 days, dependent on growth. Once isolated 
colonies were available, a sterile inoculating needle was used to stab the 
colonies into diluted tryptic soy agar (TSA) preservation vials composed of one 
gram of tryptic soy broth (TSB) and 0.3 grams of granulated agar dissolved into 
100 milliliters of distilled water. The samples were then refrigerated for 
preservation. The remainder of the isolated colony was utilized for gram staining.  
 
Gram Staining Bacterial Samples  
 Each sample contained two-three variable colonies that were isolated and 
gram stained for identification. The glass slides were washed using Lava soap 
and dried with Kimberly-Clark Kimwipes EX-L. Upon drying, a dropper was used 
to place a single drop of distilled water on each slide. A sterile isolation needle 
was used to stab individual colonies that were evenly dispersed within the water 
drop and allowed to air-dry prior to being heat fixed to the slide.  Once heat-fixed, 
the slides were flooded with Gram’s crystal violet and allowed to stand for one 
minute and rinsed completely with distilled water. The slide was then flooded with 
iodine for one minute and rinsed with three to four passes of 95 percent ethanol, 
then rinsed with distilled water. Finally, the slide was flooded with safranin to 
counter-stain the bacterial cell; after sitting for a minute was once again, rinsed 
with distilled water. A Fisherbrand Bibulous Paper pamphlet was used to dry the 
slides prior to viewing under the microscope. Samples were observed under oil-
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immersion and classified as either gram positive or gram negative and for the 
presence of bacilli or cocci. A percentage of the four categories was gathered 
and gram negative bacilli samples were removed from experimentation. Several 
of the samples were further characterized to determine the genus and species of 
those bacteria that were recurrent.  
 
Media Preparation 
 Several different types of media were utilized for this experiment. Blood 
agar was mixed for samples that did not grow well on Mueller Hinton agar, 
particularly those that required an anaerobic environment. To make the blood 
agar, 49.4 grams of Heart Infusion agar was dispensed into 950 milliliters of 
water and boiled to dissolve, prior to being autoclaved for 15 minutes. After 
cooling in a water bath set to 57 degrees Celsius, 50 milliliters of sheep blood 
was added to the solution and mixed on a stir plate, utilizing a stir bar. Plates 
were poured immediately, thereafter. Mueller Hinton plates were prepared for 
disc susceptibility because the starch included in the mixture protects against 
toxic material and controls the levels of inhibitors, especially those against 
tetracycline and sulfamides, which reduces interference with testing and allows 
for proper growth. The Mueller-Hinton mixture included two grams of beef 
extract, 17.5 grams of casamino acids, 1.5 grams of starch and 15 grams of 
agar, suspended in 1000 milliliters of distilled water. A liter of Mueller-Hinton 
plates, supplemented with 50 milliliters of sheep blood was prepared for samples 
that did not grow well on Mueller-Hinton alone. These plates were boiled for 
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mixture, placed in the autoclave for 20 minutes, cooled in the water bath under 
the same conditions previously detailed and poured into plates at equal depths of 
four millimeters. Difco Reinforced Clostridial Medium was utilized for initial 
sampling because of its success in allowing the growth of P. acnes in previous 
research. Thirty-eight grams of the powder was mixed with 15 grams of agar and 
boiled, prior to being autoclaved and following the before-mentioned procedure.   
 Actinomyces broth was selected for liquid suspensions because it is ideal 
for the growth of Actinobacteria, which is the class under which, 
Propionibacterium are filed.   In order to make Actinomyces broth, the following 
formula was followed: two grams of heart muscle infusion, 17 grams of 
pancreatic digest of Casein, 10 grams of yeast extract, five grams of sodium 
chloride, 13 grams of dipotassium phosphate, two grams of monopotassium 
phosphate, five grams of dextrose, one gram of ammonium sulfate, L-cystein 
hydrochloric acid and soluble starch, 0.2 grams of magnesium sulfate and 0.01 
grams of calcium chloride. All ingredients were dissolved into one liter of distilled 
water and brought to a boil, prior to being poured into a one-liter flask. A 
Filamatic vial filler was used to evenly dispense five milliliters of sample in to 
each test tube, prior to autoclaving for 20 minutes.  
 
Microbial Species Identification and Kirby Bauer Susceptibility 
 The refrigerated samples were set-aside for the duration of molecular 
amplification. Upon utilization of the tubes, the isolated colonies were transferred 
from the TSA tubes to Actinomyces broth using a sterile inoculating needle. Once 
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suspended in culture, samples were allowed to grow for 2-3 days before they 
were examined. Upon examination, samples without growth were placed back in 
to the incubator for 2-3 more days, depending on culture. Samples with growth 
were labeled as A and B, if two different colonies were isolated. Each sample 
was streaked onto RCM for isolation using a sterile inoculating loop and placed 
back in to the incubator at 37 degrees Celsius to grow for two days. After two 
days, samples with visible growth were removed and an individual colony from 
each plate was removed for gram staining on a glass slide. Those without visible 
growth were re-swabbed onto RCM and placed in an anaerobic jar.  
 Actinomyces broth overnight suspensions of each sample were also used 
for Mueller-Hinton inoculation. A sterile cotton swab was dipped into the 
suspension and rolled onto Mueller-Hinton agar, completely covering the plate. 
Once inoculated, each plate sat for five minutes to dry prior to adding the BBL 
Sensi-Disc Antimicrobial Susceptibility test discs. Each sample was streaked 
onto two plates and divided evenly down the middle. On each side, an antibiotic 
disk was placed using sterilized forceps that had been dipped into alcohol and 
passed through the Bunsen burner prior to placing each antibiotic disc. The 
following disks were used for all samples: rifampin, clindamycin, doxycycline and 
tetracycline. Once the disks were placed, the plates were allowed to dry for five 
minutes prior to inversion and placement in the incubator at 37 degrees Celsius 
for 48 hours. Once 48 hours had passed, the zones of inhibition surrounding 
each disc were measured in millimeters and recorded. 
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Molecular Species Identification 
 The samples placed in PBS buffer were utilized as the template for 
polymerase chain reaction amplification applying routine thermocycler conditions. 
The initial denaturation of the DNA sample was at 95 degrees Celsius for five 
minutes prior to 30 cycles through the following conditions: 95 degrees Celsius 
for 30 seconds, an annealing temperature varying between 45-68 degrees 
Celsius for 30 seconds and 72 degrees Celsius for 30 seconds. The final 
extension cycle was completed at 72 degrees Celsius for ten minutes, 
immediately followed by an infinite hold temperature at four degrees Celsius.  A 
ten-picamole/lambda primer mixture was created from the working stock of each 
forward and reverse primer set.  Twenty microliter solutions were prepared prior 
to being placed in the MyCycler thermal cycler. The concentration consisted of 
ten microliters of 2X Eco-Taq MasterMix, five microliters of the template and 2.5 
microliters of both the forward and reverse primers. Four different sets of primers, 
ordered from Integrated DNA Technologies, were selected based on previous 
research summarized in Table 2 and were amplified using the same PCR 
parameters previously described with the only variation being the annealing 
temperature based five degrees below the boiling point of each set of primers. 
The first primer utilized was Propionibacterium acnes forward (5’-GCG TGA GTG 
ACG GTA ATG GGT A-3’) and Propionibacterium acnes reverse (5’-TTC CGA 
CGC GAT CAA CCA-3’) (De Morais Cavalcanti et al, 2011). The annealing 
temperature selected for P. acnes was 52 degrees Celsius. The primer selected 
for Staphylococcus aureus was SA2-F (5’-AAT CTT TGT CGG TAC ACG ATA 
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TTC TTC ACG -3’) and SA2-R (5’- CGT AAT GAG ATT TCA GTA GAT AAT 
ACA ACA-3’) with an annealing temperature of 48.5 degrees Celsius (Saruta et 
al, 1997).  The primers utilized for Staphylococcus epidermidis amplification were 
SE1-F (5’-ATC AAA AAG TTG GCG AAC CTT TTC A-3’) and SE1-R (5’-CAA 
AAG AGC GTG GAG AAA AGT ATC A-3’) with an annealing temperature of 51 
degrees Celsius (Pereira et al., 2010).  
Primers  Primer Sequence 
PacnesF 5’-GCG TGA GTG ACG GTA ATG GGT A -3’ 
PacnesR 5’-TTC CGA CGC GAT CAA CCA -3’ 
SA2-F 5’-AAT CTT TGT CGG TAC ACG ATA TTC TTC ACG -3’ 
SA2-R 5’- CGT AAT GAG ATT TCA GTA GAT AAT ACA ACA-3’ 
SE1-F 5’-ATC AAA AAG TTG GCG AAC CTT TTC A-3’ 
SE1-R 5’-CAA AAG AGC GTG GAG AAA AGT ATC A-3’ 
Table 2. List of primers used for species identification 
 
Molecular Resistance Gene Amplification  
 Primers selected for resistance gene amplification were placed in the PCR 
Thermocycler under the same parameters used for species identification with the 
exception of specific annealing temperatures. To test for the presence of the 
erm(X) gene, the primer pair of Cerm 1 (5’-GAC ACG GCC GTC ACG AGC AT-
3’) and Cerm 2 (5’-GGC GGC GAG CGA CTT CC-3’) was used at an annealing 
temperature of 57.5 degrees Celsius (Perez et al., 2010). This gene tested for 
generic resistance to macrolides, lincosamides and streptogramins. The second 
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resistance gene utilized was tet(M), composed of TetM-F (5’-ACA GAA AGC TTA 
TTA TAT AAC-3’) and TetM-R (5’-TGG CGT GTC TAT GAT GTT CAC-3’) 
(Seyfried et al., 2010).   
 
Gel Electrophoresis 
 A two-percent agarose gel was utilized for gel electrophoresis. One gram 
of agarose was dissolved into 50 milliliters of 1X TAE buffer. The solution was 
boiled for 30-40 seconds until completely dissolved. Three microliters of ethidium 
bromide was added to the agarose, and was poured into a gel-casting tray for 
solidification. Two 15 well combs were placed at equal distance in the gel-casting 
tray. After 30 minutes, the gel-casting tray was placed in the gel electrophoresis 
apparatus and the agarose gel was completely submerged in TAE buffer prior to 
removing the combs. Eight microliter aliquots of each sample was pipetted into 
separate wells from left to right. Five microliters of 100bp DNA ladder with a 
500ng/6microliter concentration was pipetted into the first lane in each comb. The 
positive and negative control for each bacterial identification reaction was 
pipetted into the second and third lanes of each comb, respectively. The sample 
was run at 100 volts for 30 minutes. Upon completion, the gel was removed and 
viewed under ultra-violet light prior to utilizing a FluorChem E to capture the 
images.  
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Subsequent Sampling 
 In order to confirm the results of the initial zones of inhibition recorded, a 
second round of samples was obtained. Two sterile cotton swabs were utilized 
and placed into distilled water. The first was used to swab in the same manner as 
before and placed directly onto RCM agar. The second swab was placed directly 
into Actinomyces broth. The RCM agar plates were allowed to grow aerobically 
at 37 degrees Celsius for 2-3 days depending on growth. This plate was utilized 
to obtain an initial sampling of colonies. The Actinomyces broth was allowed to 
grow in the same fashion, providing an anaerobic environment for P. acnes. 
Once the broth was fairly turbid, a sterilized inoculating loop was placed into the 
mixture and an isolation streak onto RCM agar was performed. A cotton swab 
was placed into the mixed Actinomyces culture and Mueller Hinton agar was 
utilized to perform disk-susceptibility on a mixed culture to observe the effect of 
the communal microbiota against antibiotics. Once colonies were isolated, half of 
colony was utilized for gram staining while the other half was used to create a 
direct broth suspension for antimicrobial Sensi-Disc susceptibility.  
 
Mueller Hinton Antimicrobial Susceptibility Replication 
 The initial protocol for susceptibility testing was revised for the replication 
procedure in order to mimic the method suggested by BD BBL Sensi-Disc. 
Because a majority of the samples observed were gram positive, more 
specifically Staphylococcus epidermidis, a direct broth suspension was created 
using 3-5 similar colonies transferred into normal saline from RCM agar plates 
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that had been incubated overnight.  The (0.5) McFarland turbidity standard was 
strictly followed as dilutions were made if cultures became too turbid. Within 15 
minutes of suspension, a sterile cotton swab was dipped directly into the sample 
and was rotated several times against the upper inside wall of the tube to remove 
excess fluid. The entire surface was streaked three times, rotating the plate 60 
degrees between each inoculation. The lid was placed on top of the plate without 
completely covering to allow for 3-5 minutes of drying prior to the addition of the 
drug-impregnated discs. The discs were placed using forceps that were sterilized 
by ethanol and flaming, allowing for the Bunsen burner to burn off remnant 
between each disc. Doxycycline, clindamycin, rifampin and tetracycline discs 
were placed on to one plate at equal distances apart. The discs were allowed to 
sit for no more than 15 minutes prior to inversion and incubation at 37 degrees 
Celsius overnight. The resulting zones of inhibition were measured and recorded 
after 24 hours, instead of the initial 48-hour incubation.  
 
Statistical Analysis 
 Statistical analysis was performed on each data sample. Mean values and 
standard deviations were calculated using Microsoft Excel. Box plots were 
analyzed using Alcula on-line box plot calculator. Quantile-quantile plots were 
performed to determined normalcy of data. Upon confirmation of normal 
distribution, a one-way analysis of variance (ANOVA) values were determined 
using Vassar Stats and double-checked against SPSS software. P-values were 
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determined for each comparison and recorded, as well as post-hoc Tukey HSD 
values to compare specific p-values between treatments.  
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CHAPTER III 
 
 
RESULTS 
 
 
Initial Sampling and Amplification 
 
 The initial 144 samples that were incubated anaerobically were utilized in 
five microliter aliquots and amplified to determine the presence or absence of 
Propionibacterium acnes, Staphylococcus aureus and Staphylococcus 
epidermidis. The comprehensive results can be visualized in Table 3 while the 
individual sampling results can be visualized in Appendix C. The size of the 
amplicon resulting from Propionibacterium acnes was 131bp and 132 out of the 
144 samples were positive for presence of the bacteria.  The amplicon from 
Staphylococcus aureus was 108 bp and only 15 out of 144 samples tested 
positive while 110 of the 144 samples tested positive for Staphylococcus 
epidermidis, with an amplicon of 124 bp.   
 
Percentage of samples containing each experimental bacteria 
Propionibacterium 
acnes 
Staphylococcus aureus Staphylococcus 
epidermidis 
132/144          91.6% 15/144       10.4% 110/144          76.4% 
Table 3 Comprehensive survey of facial microbiota.   
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Resistance Gene Amplification 
 The same 144 samples were utilized in five microliter aliquots and amplified 
to determine the presence or absence of two common antibiotic resistance genes 
found in bacteria. The results are tabulated in Table 4.  Samples were grouped based 
on consumption of antibiotics. The tet(M) resistance gene amplicon was 200 bp 
while the Cerm(X) resistance gene amplicon was 390bp. Thirty-six participants were 
placed in group zero, suggesting no antibiotic consumption in the last two years. In 
this group, 22 tested positive for tet(M) while 18 tested positive for Cerm(X). 
Participants placed in group one had taken antibiotics within the last two years for 
various illnesses. Out of the 74 participants in this group, 51 tested positive for 
tet(M) while only 31 tested positive for Cerm(X). A very small subset of participants 
was placed into group two for consumption of antibiotics specifically for acne within 
the last two years. Five of them tested positive for tet(M) while three of them tested 
positive for Cerm(X). The last group consisted of 28 participants who had taken 
antibiotics for both acne and general illnesses within the last two years. In this 
group, 19 tested positive for tet(M) while 10 tested positive for Cerm(X). In totality, 
61% of participants not taking any antibiotics tested positive for tet(M) and 50% 
tested positive for Cerm(X).  The percentage of tet(M) presence increased by eight 
percent in participants taking antibiotics while presence of Cerm(X) resistance 
genes decreased nine percent.  
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Percentage of resistance genes present within each group of participants 
Group 0 Group 1 Group 2 Group 3 
Tet(M) Cerm(X) Tet(M) Cerm(X) Tet(M) Cerm(X) Tet(M) Cerm(X) 
22/36 18/36 51/74 31/74 5/6 3/6 19/28 10/28 
61% 50% 69% 42% 83% 50% 68% 36% 
Table 4. Antibiotic Resistance Genes. Comparison of the percentages of antibiotic 
resistance genes found within each group. 
 
 
Susceptibility Testing  
 Once all of the resistance genes were amplified, isolated samples that were 
placed in TSA tubes were utilized to determine susceptibility.  Samples from each 
group were randomly selected and the resulting zones of inhibition were compared 
against the guidelines outlined in the BD BBL Sensi-Disc Antimicrobial Susceptibility 
pamphlet, summarized in Appendix T. Out of the 60 samples in the first 
susceptibility testing, 22 were classified as resistant, while 8 were intermediately 
susceptible and 30 were susceptible to clindamycin. When comparing those results 
to the presence of Cerm(X) resistance genes, molecularly, 34 of the results were 
double confirmed while 26 were contradictory.  These results can be summarized in 
Table 5.  
Sample Zone of 
Inhibition 
 (mm) 
Resistant 14.0 
Intermediate 15-20 
Susceptible≥21 
Cerm 
+/- 
1A 25 Susceptible - 
1B 0 Resistant - 
2B 6 Resistant - 
3A 0 Resistant + 
3B 0 Resistant + 
4B 13  Resistant - 
5A 13 Resistant + 
5B 0 Resistant + 
7B 20 Intermediate - 
9A 0 Resistant - 
  31 
9B 7  Resistant - 
9C 40 Susceptible - 
13A 24 Susceptible - 
13B 21 Susceptible - 
17A 7 Resistant + 
17B 11 Resistant + 
18A 11 Resistant + 
18B 23  Susceptible + 
21A 26 Susceptible - 
21B 9 Resistant - 
22A 30 Susceptible + 
25A 30 Susceptible + 
25B 29 Susceptible + 
28A 0 Resistant + 
28B 23 Susceptible + 
30A 26 Susceptible + 
30B 24 Susceptible + 
31A 0 Resistant + 
31B 9 Resistant + 
32A 44 Susceptible - 
32B 7 Resistant - 
34A 21 Susceptible + 
34B 16 Intermediate + 
36A 20 Intermediate - 
36B 26 Susceptible - 
37A 22 Susceptible + 
37B 16 Intermediate + 
39A 0 Resistant - 
39B 0 Resistant - 
42A 23 Susceptible - 
42B 22 Susceptible - 
44A 19 Intermediate - 
44B 30 Susceptible - 
44C 34 Susceptible - 
47A 26 Susceptible - 
47B 20 Intermediate - 
49A 26.5 Susceptible + 
49B 11 Resistant + 
50A 26 Susceptible + 
50B 0 Resistant + 
50C 25 Susceptible + 
53B 18 Intermediate - 
87B 38 Susceptible - 
101 40 Susceptible - 
  32 
118A 25 Susceptible - 
118B 30 Susceptible - 
123A 19 Intermediate + 
123B 0 Resistant + 
125A 24 Susceptible + 
125B 26 Susceptible + 
Table 5. Clindamycin ZOI and Resistance Genes. Classifications of susceptibility 
in comparison to the presence of the resistance gene, Cerm(X).  
 
 The same 60 samples were also tested against tetracycline to determine 
susceptibility. Only seven on the samples were classified as resistant while none 
were deemed intermediate, leaving the remaining 53 samples to be classified as 
susceptible. When comparing the zones of inhibition to the molecular amplification 
of the resistance gene tet(M), 28 samples were double confirmed while 32 were 
contradictory. The results are summarized in Table 6.  
 
Sample Zone of 
Inhibition 
 (mm) 
Resistant ≤14.0 
Intermediate 15-18 
Susceptible ≥ 19 
Tet(M)  
+/- 
1A 38 Susceptible + 
1B 13 Resistant + 
2B 39 Susceptible - 
3A 10 Resistant + 
3B 8 Resistant + 
4B 21 Susceptible - 
5A 21 Susceptible - 
5B 32 Susceptible - 
7B 32 Susceptible - 
9A 22 Susceptible + 
9B 23 Susceptible + 
9C 28 Susceptible + 
13A 27 Susceptible + 
13B 21 Susceptible + 
17A 42 Susceptible - 
17B 37 Susceptible - 
18A 38 Susceptible + 
18B 20 Susceptible + 
21A 22 Susceptible + 
21B 31 Susceptible + 
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22A 10 Resistant + 
25A 36 Susceptible + 
25B 31 Susceptible + 
28A 24 Susceptible + 
28B 32 Susceptible + 
30A 28 Susceptible - 
30B 27 Susceptible - 
31A 30 Susceptible + 
31B 30 Susceptible + 
32A 30 Susceptible + 
32B 34 Susceptible + 
34A 25 Susceptible - 
34B 28 Susceptible - 
36A 39 Susceptible + 
36B 36 Susceptible + 
37A 46 Susceptible - 
37B 32 Susceptible - 
39A 11 Resistant - 
39B 37 Susceptible - 
42A 27 Susceptible + 
42B 34 Susceptible + 
44A 36 Susceptible - 
44B 44 Susceptible - 
44C 26 Susceptible - 
47A 12 Resistant + 
47B 10 Resistant + 
49A 35 Susceptible - 
49B 36 Susceptible - 
50A 27 Susceptible + 
50B 22 Susceptible + 
50C 27 Susceptible + 
53B 35 Susceptible - 
87B 27 Susceptible + 
101 44 Susceptible + 
118A 34 Susceptible - 
118B 58 Susceptible - 
123A 25 Susceptible + 
123B 31 Susceptible + 
125A 32 Susceptible + 
125B 27 Susceptible + 
Table 6. Tetracycline ZOI and Resistance Genes. Classifications of 
susceptibility in comparison to presence of antibiotic resistance gene tet(M).  
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 Along with tetracycline and clindamycin, zones of inhibition were 
measured for rifampin and doxycycline and individual results are summarized in 
Appendix C. In Figure 1, samples were divided into three categories instead of 
four. Group zero consisted of samples taken from those who did not take 
antibiotics in the last two years, while group one is an antibiotic taken for either 
general illnesses or acne and group two is antibiotics taken for both general 
illnesses and acne. For each type of antibiotics, there is a slight decrease in the 
zone of inhibition in participants who have taken antibiotics for both acne and 
general illnesses in comparison with those who have not taken antibiotics in the 
past two years, with rifampin as the only exception. The results for rifampin were 
fairly similar among the different groups. Mean values for Tet0, Tet1 and Tet2 
were 29.95, 29.65 and 28.27 millimeters respectively with a 1.68-millimeter 
decrease in diameter between TetO and Tet2. Mean values for Clinda0, Clinda1 
and Clinda 2 were 22.21, 16.88 and 13.27 millimeters respectively with an 8.94-
millimeter decrease in diameter between Clinda0 and Clinda2. Mean values for 
Rif0, Rif1 and Rif2 were 42.83, 44.94 and 43.93 millimeters respectively. The 
mean values for Doxy0, Doxy1 and Doxy2 were 33.57, 34.25 and 32.80 
respectively with 0.77-millimeter decrease in diameter between Doxy0 and 
Doxy2. Standard deviations were also calculated.  
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Figure 1. Comparison of mean zones of inhibition between categories in 
the first susceptibility testing (p<0.001). Participants are grouped similarly with 
the exception of category one and two, which were combined. P-value comparing 
Clinda0 and Clinda2 was 0.038 while comparison of Clinda0, 1 and 2 was 0.075.  
 
 
Morphology Confirmation  
 
 In order to determine the zones of inhibition, each of these isolated 
samples were gram stained for morphology. A majority of the samples were gram 
positive, which were streaked onto Mannitol Salt agar (MSA) plates to check for a 
yellow color change. After salt preference was determined, samples were tested 
for catalase production utilizing hydrogen peroxide and the appearance of 
bubbles. A comprehensive list of microorganisms isolated can be found in 
Appendix C. Out of all isolated samples that were randomly tested for 
susceptibility, 44 were Staphylococcus epidermidis strains, while six were 
Propionibacterium acnes and six were Staphylococcus aureus. Three of the 
isolates were Micrococcus spp, with one Enterococcus isolate and two gram 
negative bacilli.  
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Figure 2. Comparison of mean zones of inhibition between categories in 
the second replication of susceptibility testing (p-value <0.001). Further 
post-hoc analysis determined the p-value resulting from the differences between 
Rif0 and Rif3 was 0.0015 while the p-value between Doxy0 and Doxy3 was 
0.007. 
 
Subsequent Susceptibility Testing 
 Another 42 samples were collected for a second round of susceptibility 
testing, following the procedure outline by BBL. Participants were grouped as 
previously outlined with group zero being no antibiotics in the last two years and 
group three being antibiotics for both acne and general illnesses. Group one 
participants have taken antibiotics only for generic illness while group two 
participants, specifically for acne. The same trend as previously observed could 
be inferred from Figure 2 where increased antibiotic use has a negative 
correlation with diameter of inhibition zones. The mean values for Tet0, Tet1, 
Tet2 and Tet3 where 29.11, 26.20, 26.83 and 24.47 millimeters respectively with 
a 4.64-millimeter decrease in diameter between Tet0 and Tet3.  Mean values for 
Clinda0, Clinda1, Clinda2 and Clinda3 were 9.81, 9.61, 6.16 and 3.47 
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respectively with a 6.34-millimeter decrease in diameter between Clinda0 and 
Clinda3. Mean values for Rif0, Rif1, Rif2 and Rif3 were 30.04, 25.31, 28.17 and 
18.18 respectively with an 11.86-millimeter decrease in diameter between Rif0 
and Rif3. Lastly, mean values for Doxy0, Doxy1, Doxy2 and Doxy3 were 32.04, 
28.39, 28.67 and 24.38 respectively with a 7.66-millimeter decrease in diameter 
between Doxy0 and Doxy3. Total classifications of resistant, intermediate and 
susceptible samples are summarized in Table 7. 
Antibiotic Tetracycline Clindamycin Rifampin Doxycycline 
Resistant  15 75 24 1 
Intermediate 14 18 9 3 
Susceptible 82 19 79 107 
Total 
Samples 
111 112 112 111 
Table 7. Comprehensive results of susceptibility testing  
 
 In Figure 3, samples were divided into antibiotic use or lack thereof, within 
the last two years. In tetracycline, there was a 3.22-millimeter decrease in the 
zone of inhibition in those who have taken antibiotics. In clindamycin, there was a 
1.67-millimeter decrease in the zone of inhibition. In Figure 4, Rifampin diameter 
decreased 5.96 millimeters in those who had taken antibiotics while there was a 
4.44-millimeter decrease in zones of inhibition around doxycycline discs.  
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Figure 3. Comparison of Mean Diameters between participants. Zone of 
inhibition comparison between participants who have taken antibiotics and those 
who have not. The p-value between Tetracycline groups was 0.14 while the p-
value for Clindamycin was 0.42. 
 
 
 
  
Figure 4. Comparison of Mean Diameters between participants. Zone of 
inhibition comparison between participants who have taken antibiotics and those 
who have not. The p-value between Rifampin groups was 0.009 while the p-
value between Doxycycline groups was 0.012 
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CHAPTER IV 
 
 
DISCUSSION 
 
 
 The development of antibiotic resistance is a phenomenon that requires 
more attention than it has been given in the past. The current estimates 
suggesting devastating increases in resistance can no longer be ignored. 
Because the facial microbiota serve as a useful indicator of resistance 
development, it only made sense to utilize the bacteria found there. If current 
research can determine the presence of existing resistance genes as well as the 
current state of resistance cultures, more attention may be drawn to the problem 
at hand, equating to increased funding of pivotal research as well as increased 
production of new, more specific antibiotics.  
 Initial bacterial identification utilizing polymerase chain reaction 
established that a majority of samples contained Propionibacterium acnes, as 
132 out of the total 144 samples were positive. Staphylococcus epidermidis was 
the second most common, with 110 positive samples while only 15 samples 
tested positive for Staphylococcus aureus, though previous research suggested 
that the figure should have been much greater. One particular explanation for a 
lack of positive S. aureus samples is too much primer, which has the potential to 
inhibit proper amplification of the bacterial DNA. Suggested final concentration of 
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each primer in a reaction should be between 0.5-1mM and the final concentration 
utilized for this experiment was 1.95mM. It should be considered, however, that if 
inhibition was possible in Staphylococcus aureus samples, it is possible other 
bacterial prevalence would have increased also because the amount of primer 
added was consistent throughout. It is also important to note that microbial 
growth under aerobic conditions validated the lack of positive Staphylococcus 
aureus samples.  
 Resistance gene amplification samples were divided into groups based on 
consumption to determine if the presence of resistance genes demonstrated any 
correlation to antibiotic use. In group zero, specifying no antibiotics in the last two 
years, 22 of the 36 samples tested positive for tet(M) while 18 tested positive for 
Cerm(X). Group one, participants taking antibiotics for general illnesses, was 
composed of 74 samples, 51 testing positive for tet(M) and 31 testing positive for 
Cerm(X). Group two, composed of six participants taking antibiotics solely for 
acne vulgaris, had five test positive for tet(M) and three for Cerm(X). The 
remainder of the participants had taken antibiotics for both acne and general 
illnesses; 19 of the 28 samples tested positive for tet(M) and 10 tested positive 
for Cerm(X). Half or more of each group tested positive for resistance to one or 
both of the resistance genes, even those who had not consumed antibiotics in 
the last two years. There was a slight increase in presence of tet(M) resistance 
between those who had not taken antibiotics and those who had taken at least 
two, though there was a decrease in prevalence of Cerm(X) between the groups. 
The prevalence of tet(M) resistance was greater than Cerm(X) across the board. 
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Theoretically, there should have been a positive correlation between the 
prevalence of resistance genes and increased antibiotic consumption. One 
particular explanation for this phenomenon could be that a majority of those who 
had taken antibiotics had not taken macrolides or tetracycline. Another 
discrepancy lies in the reporting of antibiotic use of participants; many could not 
recall which antibiotic they had taken and some were unsure as to which 
prescriptions were classified as antibiotics.    
 Once resistance genes were amplified, susceptibility testing was 
performed. Sixty samples were tested using the first protocol outlined with 22 
demonstrating resistance to clindamycin, eight intermediate and 30 were 
susceptible. Comparing these results to gene amplification, 34 results were 
double confirmed while 26 were contradictory. Of the sixty samples, only seven 
tested positive for resistance to tetracycline while the rest were susceptible and 
only 28 were double-confirmed by the presence of tet(M). The samples used for 
susceptibility testing were grown overnight and measured after 48 hours. The 
guidelines in the BBL pamphlet recommend direct colony suspension for gram-
positive samples while suggesting that overnight suspensions are not preferred. 
The samples should have been checked after 24 hours, instead of 48. In 
comparing the presence of resistance genes with the results of the susceptibility 
testing, the contradictions are not necessarily reliable because each sample used 
for molecular amplification were mixed cultures while the samples utilized for 
susceptibility were isolated colonies. Though some were susceptible, it is not 
entirely suggestive of susceptibility throughout, but individually. In order to test 
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the entirety, one would have to isolate each colony present and test them. I 
isolated colonies based on control samples of Propionibacterium acnes, 
Staphylococcus aureus and Staphylococcus epidermidis. In each mixed sample, 
there may have been several strains of each bacterium, some of which carried 
the resistance gene amplified but was not the particular colony isolated.  
 It is also important to acknowledge the selective pressures that are forced 
upon bacteria by antibiotic use. Removing the bacteria from the environment that 
exposed them to such selective pressures may allow them to revert back to 
susceptible strains once allowed to multiply in incubation. The samples placed in 
PBS buffer were frozen and the environment leaves little to no room for 
replication. This phenomenon could help explain the discrepancy between the 
presences of resistance genes molecularly but demonstrated susceptibility when 
utilizing the Kirby Bauer method microbiologically.  
 Although the protocol from the initial 60 samples was not ideal, there was 
still a slight, if not great, decrease in the diameter of the zone of inhibition with 
greater consumption of antibiotics; rifampin was the only exception. This trend 
highlights the fact that increased antibiotic use leads to greater resistance or at 
least, decreased inhibition of the bacteria. With a p-value of <0.001, further 
analysis demonstrated that there was significant difference across the board with 
clindamycin use. The p-value was 0.038 when comparing no antibiotic use to 
double antibiotic use while the p-value was 0.075 comparing no antibiotic use 
against both one and two types of antibiotic use. Rifampin testing results were 
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expected because there were no participants reporting the use of rifampin and 
previous research suggests no evidence of rifampin resistance in acne.  
 In order to confirm the decrease in zones of inhibition, a second round of 
susceptibility testing was performed utilizing the second protocol and direct 
colony suspensions. The trend was confirmed in greater magnitude. The lowest 
decrease in diameter with increased antibiotic consumption was 4.64 millimeters. 
The most surprising decrease was the 11.86-millimeter decrease when exposed 
to rifampin between those who had not taken antibiotics and those who had 
taken two types of antibiotics. The decrease is evident even between those who 
had not taken antibiotics in the last two years and those who had only used 
antibiotics for general illnesses. The p-value for the entire comparison was less 
than 0.001 and further analysis demonstrated that the difference between Rif0 
and Rif3 was 0.0015 and 0.007 between Doxy0 and Doxy3. Dividing the samples 
into two groups based on antibiotic use or lack thereof, the decrease was still 
evident with a p-value of <0.01 between rifampin samples and 0.012 between 
doxycycline samples.  
 Though there were several significant differences and correlations that 
suggest increased antibiotic use causes a decrease in susceptibility to 
antibiotics, there are several ways to improve this thesis. If I were to restart this 
experiment, I would select a smaller sample size and would have isolated every 
single individual colony present and would have placed those immediately into 
PBS buffer and performed polymerase chain reaction on isolated rather than 
mixed cultures. I would have found Mueller-Hinton results for every single colony 
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as well rather than a smaller subset of the initial population sampling. In 
subsequent experiments, I would do an initial measurement of the zone of 
inhibition and then, would have duplicated the experiment to test successive 
encounters with previously used antibiotics in vitro, utilizing the bacteria closest 
to the zone of inhibition. An interesting phenomenon that occurred frequently in 
this research was the presence of mutant colonies within the zones of inhibition 
on plates that had been exposed to rifampin.  It would be beneficial to isolate 
those colonies and determine the resistance development occurring in 
successive encounters to the same antibiotic, especially considering previous 
research has not suggested significant rates of antibiotic resistance development 
while testing rifampin. Another trajectory that would be interesting for this 
research would be to utilize Staphylococcus epidermidis and its proven inhibition 
of Propionibacterium acnes in the battle against it.  
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Appendix A: Initial Survey of Antibiotic Use  
 
 
 
 
 
 
Appendix B: Initial Survey of Specific Antibiotics Prescribed. 
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Sample Tetra 
(mm) 
Clindamycin 
(mm) 
Rifampin 
(mm) 
Doxy 
(mm) 
Gram     
+/- 
Organism 
1A 38 25 47 26 + Micrococcus 
1B 13 0 46 45 + S. epidermidis  
2A 42 13 59 36 -  
2B 39 6 31 22 + P. acnes 
3A 10 0 41 18 + S. epidermidis 
3B 8 0 49 20 + S. epidermidis 
4B 21 13 33 22 + S. epidermidis 
5A 21 13 21 31.5 + P. acnes 
5B 32 0 46 34 + S. epidermidis 
7B 32 20 40 37 + S. aureus 
9A 22 0 58 24 + S. epidermidis 
9B 23 7 54 24 + S. epidermidis 
9C 28 4 58 41 + S. epidermidis 
13A 27 24 42 29 + S. epidermidis 
13B 21 21 45 29 + S. epidermidis 
17A 42 7 44.5 43 + S. epidermidis 
17B 37 11 48 43 + S. epidermidis 
18A 38 11 21 40 + S. epidermidis 
18B 20 23 62 43 + S. epidermidis 
21A 22 26 54 24 + S. epidermidis 
21B 31 9 45 40 + P. acnes 
22A 10 30 36.5 34 + S. epidermidis 
22B 42 46 51 49 -  
25A 36 30 41 43 + S. aureus 
25B 31 29 46 27.5 + S. epidermidis 
28A 24 0 46.5 25 + S. epidermidis 
28B 32 23 40 31 + P. acnes 
30A 28 26 46 31 + S. epidermidis 
30B 27 24 33 30 + S. epidermidis 
31A 30 0 46 35 + Micrococcus 
31B 30 9 42 29 + S. epidermidis 
32A 30 44 49 32 + S. epidermidis 
32B 34 7 54 30 + S. epidermidis 
34A 25 21 11 30 + S. epidermidis 
34B 28 16 45 33 + S. epidermidis 
36A 39 20 52 42 + S. epidermidis 
36B 36 26 48 42 + S. epidermidis 
37A 46 22 64 48 + S. epidermidis 
37B 32 16 64 48 + S. epidermidis 
39A 11 0 58 23 + S. epidermidis 
39B 37 0 52 43 + S. epidermidis 
42A 27 23 43 30 + S. aureus 
42B 34 22 42 36 + S. epidermidis 
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44A 36 19 44 39 + S. epidermidis 
44B 44 30 44 45 + S. epidermidis 
44C 26 34 33 31 + Enterococcus 
47A 12 26 52 21 + S. epidermidis 
47B 10 20 42 16.5 + S. aureus 
49A 35 26.5 44 40 + S. epidermidis 
49B 36 11 24 36 + P. acnes 
50A 27 26 52 32 + S. epidermidis 
50B 22 0 36 24 + Micrococcus 
50C 27 25 48 28 + S. epidermidis 
53B 35 18 40 38.5 + S. epidermidis 
87B 27 38 35 39 + S. epidermidis 
101 44 40 61 46 + P. acnes 
118A 34 25 42 36 + S.aureus 
118B 58 30 38 60 + S. epidermidis 
123A 25 19 34 25.5 + S. epidermidis 
123B 31 0 35 31 + S. epidermidis 
125A 32 24 36 31 + S. epidermidis 
125B 27 26 32.5 25 + S. aureus 
Appendix C: Table of Susceptibility, Morphology and Species Identification  
 
 
 
Presence and absence of organisms and resistance genes in those 
categorized in group 0: having taken no antibiotics within the last two years 
Sample Tet(M) Cerm(x) P. acnes  S. aureus S. 
epidermidis 
2 - - + - + 
3 + + + - + 
6 - - + - + 
16 + + + - + 
21 + - + - + 
22 + + + - + 
25 + + + - + 
30 - + + - + 
32 + - + - + 
38 + + + - + 
40 + + + - + 
44 - + + - + 
45 + + + - + 
48 + - - - + 
53 - - + + - 
54 - - + - + 
58 - - + + - 
59 + + + - + 
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64 + - + - + 
66 - + + - + 
75 - - + - + 
76 - + + - - 
83 + - + - + 
85 - - + - + 
86 + - - - + 
87 + - - - + 
97 - + + - + 
99 - - + - + 
104 - + + - - 
105 + - + - + 
110 + - + + + 
114 + - + + + 
120 + + + + - 
131 + + + - + 
134 + + + - + 
137 + + + - + 
Appendix D: Results of Each Amplification in Group Zero 
 
 
 
Presence and absence of organisms and resistance genes in those 
categorized in group 1: having taken antibiotics for general illnesses, not 
including acne  
Sample Tet(M) Cerm(X) P. acnes S. aureus S. 
epidermidis 
4 - - + - + 
5 - + + - + 
7 - - + - - 
8 - - + - + 
9 + - + - + 
10 + + + - + 
11 - - + - + 
12 + + + - + 
13 + - + - + 
15 + - + - + 
18 + + + - + 
19 - + + - + 
20 + - + - + 
23 + - + - + 
27 - - + - + 
29 + - + - + 
31 + - + - + 
35 + - + - + 
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36 + - + - + 
37 - + + - + 
41 + - + - + 
43 + - + - + 
52 - + + - + 
55 - - + - - 
56 + + + - + 
57 + - + - + 
60 + - + - + 
61 + - + - + 
63 - + + - - 
65 - - + - + 
67 + + + - +` 
69 + - + - + 
70 + + + - - 
71 - + + - + 
72 + - + - + 
73 + + + - - 
77 - - + - - 
79 + - - - - 
80 - - - - + 
81 + + - - + 
84 + + + - + 
88 - - + + + 
89 - - + - + 
90 + - + - - 
93 + + + - + 
94 - - + - - 
95 + + + - + 
98 + - + - + 
100 + - - - - 
101 + - + + + 
102 + - + - + 
108 + + + - + 
111 + + + + + 
113 - + + - + 
115 + + + + + 
116 + + - + - 
117 + - + - + 
118 - - - - - 
119 + - + + + 
121 - + + - + 
123 + + + - + 
124 - - + - - 
126 - + + - - 
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128 + + + - + 
129 + - + - + 
133 + + + - + 
135 + + + - + 
136 + + + - + 
138 + + + - + 
139 + - + - - 
140 + - + - + 
142 + - + - + 
143 + + + - + 
144 + - + - + 
Appendix E: Results of Each Amplification in Group One  
 
 
 
 
 
 
Presence and absence of organisms and resistance genes in those 
categorized in group 2: those having taken antibiotics specifically for acne only 
Sample Tet(M) Cerm(X) P. acnes S. aureus S. 
epidermidis 
26 + + + - + 
47 + - + - - 
68 - - + - - 
96 + - + - - 
125 + + + - + 
141 + + + - + 
Appendix F: Results of each amplification designated to group two 
 
 
 
 
 
 
 
Presence and absence of organisms and resistance genes in those 
categorized in group 3: those having taken both antibiotics for general illnesses 
and acne 
Sample Tet(M) Cerm(X) P. acnes S. aureus S. 
epidermidis 
1 + - + - + 
14 + + + + + 
17 - + + - - 
24 + + - - + 
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28 + + + - + 
33 - - + - - 
34 - + + - + 
39 - - + - - 
42 - - + - + 
46 + - + - + 
49 - + + - + 
50 + + + + - 
51 + - + - + 
62 + - - - - 
74 + - + - - 
78 - - + - - 
82 + + + - + 
91 + - + + + 
92 - - + - - 
103 + - + - - 
106 + - + - + 
107 + - + - + 
109 - - - + - 
112 + - + - - 
122 + + + - + 
127 + - + - + 
130 + - + - - 
132 + + + - + 
Appendix G: Results of Each Amplification in Group Three  
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Appendix H: Common Morphologies-Gram Stains. Top left is a gram-positive 
bacilli (Bacillus spp), top right is gram-positive cocci (S. epidermidis), bottom left 
(S. aureus), and bottom right is common initial swab mixture.  
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Doxycycline & Rifampin ZOI in Gram Positive Organisms 
Sample Doxycycline 
ZOI 
(mm) 
R≤12.0 
(I) 13-15 
S ≥16 
Rifampin 
ZOI 
(mm) 
R≤16.0 
(I) 17-19 
S≥20 
1A 26 S 47 S 
1B 45 S 46 S 
2B 22 S 31 S 
3A 18 S 41 S 
3B 20 S 49 S 
4B 22 S 33 S 
5A 31.5 S 21 S 
5B 34 S 46 S 
7B 37 S 40 S 
9A 24 S 58 S 
9B 24 S 54 S 
9C 41 S 58 S 
13A 29 S 42 S 
13B 29 S 45 S 
17A 43 S 44.5 S 
17B 43 S 48 S 
18A 40 S 21 S 
18B 43 S 62 S 
21A 24 S 54 S 
21B 40 S 45 S 
22A 34 S 36.5 S 
25A 43 S 41 S 
25B 27.5 S 46 S 
28A 25 S 46.5 S 
30A 31 S 46 S 
30B 30 S 33 S 
31A 35 S 46 S 
31B 29 S 42 S 
32A 32 S 49 S 
32B 30 S 54 S 
34A 30 S 11 R 
34B 33 S 45 S 
36A 42 S 52 S 
36B 42 S 48 S 
37A 48 S 64 S 
37B 48 S 64 S 
39A 23 S 58 S 
39B 43 S 52 S 
42A 30 S 43 S 
42B 36 S 42 S 
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44A 39 S 44 S 
44B 45 S 44 S 
44C 31 S 33 S 
47A 21 S 52 S 
47B 16.5  S 42 S 
49A 40 S 44 S 
49B 36 S 24 S 
50A 32 S 52 S 
50B 24 S 36 S 
50C 28 S 48 S 
53B 38.5 S 40 S 
87B 39 S 35 S 
101 46 S 61 S 
118A 36 S 42 S 
118B 60 S 38 S 
118B 60 S 38 S 
123A 25.5 S 34 S 
123B 31 S 35 S 
125A 31 S 36 S 
125B 25 S 32.5 S 
Appendix I: Comprehensive Results for Doxycycline and Rifampin 
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Appendix J: P acne primer samples. Top left are samples 10-21, top right are 
samples 38-43 and 92-98, bottom right are samples 44-67 and bottom left is 68-
91. 
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Appendix K: P. acne primer samples. Samples 99-122, 123-140, 2-9 and 
repeats for double confirmation and samples 141-144.   
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Appendix L: S. aureus primers. Top left are samples 1-24, top right is samples 
25-48, bottom left are samples 49-72 and bottom right are samples 73-96.  
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Appendix M: S. aureus primers. Top left are samples 97-120, top right are 
samples 121-140. Bottom left are sample repeats for confirmation and right are 
samples 120, 141-144.  
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Appendix N: S. epidermidis primers. Top left are samples 1-24 and top right 
are samples 25-48. Bottom left are samples 49-72 and right are samples 73-96.  
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Appendix O: S. epidermidis samples. Top left are samples 97-120 and top 
right are samples 121-144. Bottom left are repeats for confirmation.   
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Appendix P: Cerm(X) resistance primers. Top left are samples 1-26, top right 
are samples 27-52, bottom left are samples 53-78 and bottom right are samples 
79-104.  
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Appendix Q: Cerm(X) resistance primers. Top left are samples 105-130, top 
right are samples 131-144. Bottom left are repeats for double confirmation.  
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Appendix R: tetM resistance primers. Top left are samples 1-25 and 83. Top 
right are samples 26-51. Bottom left are samples 52-78 and 82. Bottom right are 
samples 79-106.  
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Appendix S: tet(M) resistance primers. Top left are samples 107-132. Top 
right are samples 133-144. Bottom left are sample repeats for double 
confirmation.  
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Appendix T: BD BBL Sensi-Disc Susceptibility Chart  
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Tetracycline Resistance  Clindamycin Resistance  
Sample 
Zone of 
Inhibition 
R ≤14 
S ≥19 Category Sample ZOI 
R ≤ 14  
S ≥ 21 Category 
145A 29 S 3 145A 21 S 3 
146A 11 R 3 146A 0 R 3 
146B 18 I 3 146B 0 R 3 
146C 20 S 3 146C 0 R 3 
146M 17 I 3 146M 0 R 3 
154A 27 S 3 154A 0 R 3 
154B 42 S 3 154B 0 R 3 
154C 43 S 3 154C 0 R 3 
154M 11 R 3 154M 0 R 3 
166A 19 S 3 166A 20 S 3 
166B 20 S 3 166B 0 R 3 
166M 18 I 3 166M 7 R 3 
167A 34 S 3 167A 0 R 3 
167M 18 I 3 167M 0 R 3 
168A 34 S 3 168A 11 R 3 
168B 32 S 3 168B 0 R 3 
168M 23 S 3 168M 0 R 3 
163A 20 S 2 163A 10 R 2 
163B 24 S 2 163B 0 R 2 
163M 26 S 2 163M 0 R 2 
165A 45 S 2 165A 10 R 2 
165B 35 S 2 165B 9 R 2 
165M 11 R 2 165M 8 R 2 
149A 37 S 1 149A 20 I 1 
149B 40 S 1 149B 11 R 1 
149M 30 S 1 149M 17 I 1 
150A 24 S 1 150A 0 R 1 
150B 26 S 1 150B 0 R 1 
150M 0 R 1 150M 0 R 1 
151A 41 S 1 151A 0 R 1 
151B 34 S 1 151B 19 I 1 
151M 32 S 1 151M 20 I 1 
152A 25 S 1 152A 17 I 1 
152B 40 S 1 152B 0 R 1 
152M 24 S 1 152M 23 S 1 
153A 23 S 1 153A 0 R 1 
153B 41 S 1 153B 0 R 1 
153M 14 R 1 153M 8 R 1 
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155A 35 R 1 155A 14 R 1 
155M 28 R 1 155M 17 I 1 
156A 17 I 1 156A 0 R 1 
156M 21 S 1 156M 17 I 1 
157A 35 S 1 157A 0 R 1 
157M 12 R 1 157M 12 R 1 
158A 26 S 1 158A 0 R 1 
158B 43 S 1 158B 0 R 1 
158C 39 S 1 158C 9 R 1 
158M 26 S 1 158M 0 R 1 
161A 40 S 1 161A 0 R 1 
161M 23 S 1 161M 0 R 1 
162A 34 S 1 162A 0 R 1 
162M 13 R 1 162M 17 I 1 
169A 30 S 1 169A 26 S 1 
169M 12 R 1 169M 7 R 1 
170A 34 S 1 170A 11 R 1 
170B 8 R 1 170B 11 R 1 
170M 13 R 1 170M 13 R 1 
171A 34 S 1 171A 17 I 1 
171M 28 S 1 171M 11 R 1 
172A 34 S 1 172A 0 R 1 
172B 18 I 1 172B 21 S 1 
172C 17 I 1 172C 15 I 1 
172M 11 R 1 172M 0 R 1 
173A 29 S 1 173A 21 S 1 
173B 11 R 1 173B 0 R 1 
173M 24 S 1 173M 9 R 1 
176A 31 S 1 176A 28 S 1 
176M 28 S 1 176M 0 R 1 
180A 40 S 1 180A 0 R 1 
180M 32 S 1 180M 0 R 1 
181A 29 S 1 181A 26 S 1 
181M 13 R 1 181M 0 R 1 
182A 14 R 1 182A 18 I 1 
182B 36 S 1 182B 0 R 1 
182M 34 S 1 182M 0 R 1 
183A 20 S 1 183A 25 S 1 
183M 16 I 1 183M 18 I 1 
184A 30 S 1 184A 24 S 1 
184M 15 I 1 184M 20 I 1 
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185A 29 S 1 185A 0 R 1 
185B 29 S 1 185B 15 I 1 
185C 22 S 1 185C 22 S 1 
185M 18 I 1 185M 2 R 1 
186A 36 S 1 186A 15 I 1 
147A 29 S 0 186M 0 R 1 
147B 41 S 0 147A 24 S 0 
147M 31 S 0 147B 24 S 0 
148A 35 S 0 147M 24 S 0 
148B 35 S 0 148A 0 R 0 
148M 44 S 0 148B 22 S 0 
159A 34 S 0 148M 23 S 0 
159M 21 S 0 159A 0 R 0 
160A 36 S 0 159M 8 R 0 
160M 23 S 0 160A 0 R 0 
164A 37 S 0 160M 16 I 0 
164B 15 I 0 164A 0 R 0 
164M 16 I 0 164B 0 R 0 
174A 35 S 0 164M 0 R 0 
174B 18 I 0 174A 22 S 0 
174C 36 S 0 174B 0 R 0 
174M 28 S 0 174C 23 S 0 
175A 24 S 0 174M 18 I 0 
175M 17 I 0 175A 0 R 0 
177A 31 S 0 175M 0 R 0 
177M 25 S 0 177A 0 R 0 
178A 38 S 0 177M 18 I 0 
178M 19 S 0 178A 0 R 0 
179A 31 S 0 178M 10 R 0 
179B 31 S 0 179A 8 R 0 
179C 42 S 0 179B 25 S 0 
179M 14 R 0 179C 0 R 0 
 179M 0 R 0 
Appendix U: Tetracycline and Clindamycin ZOI Organized by Category 
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Rifampin Resistance  Doxycycline Resistance 
Sample ZOI 
R ≤ 16 
S ≥ 20 Category Sample ZOI 
R ≤ 12 
S ≥ 16 Category 
145A 15 R 3 145A 30.5 S 3 
146A 45 S 3 146A 25 S 3 
146B 8 R 3 146B 17 S 3 
146C 9 R 3 146C 17 S 3 
146M 8 R 3 146M 14 I 3 
154A 11 R 3 154A 26 S 3 
154B 25 S 3 154B 40 S 3 
154C 24 S 3 154C 39 S 3 
154M 22 S 3 154M 17 S 3 
166A 20 S 3 166A 26 S 3 
166B 9 R 3 166B 18 S 3 
166M 10 R 3 166M 19 S 3 
167A 26 S 3 167A 30 S 3 
167M 24 S 3 167M 22 S 3 
168A 20 S 3 168A 35 S 3 
168B 23 S 3 168B 20 S 3 
168M 10 R 3 168M 19 S 3 
163A 37 S 2 163A 30 S 2 
163B 24 S 2 163B 33 S 2 
163M 21 S 2 163M 24 S 2 
165A 42 S 2 165A 42 S 2 
165B 35 S 2 165B 34 S 2 
165M 10 R 2 165M 9 R 2 
149A 32 S 1 149A 40 S 1 
149B 36 S 1 149B 40 S 1 
149M 41 S 1 149M 27 S 1 
150A 26 S 1 150A 33 S 1 
150B 25 S 1 150B 33 S 1 
150M 41 S 1 150M 18 S 1 
151A 24 S 1 151A 38 S 1 
151B 18 I 1 151B 35 S 1 
151M 16 R 1 151M 31 S 1 
152A 19 I 1 152A 28 S 1 
152B 25 S 1 152B 38 S 1 
152M 12 R 1 152M 26 S 1 
153A 18 I 1 153A 28 S 1 
153B 19 I 1 153B 37 S 1 
153M 39 S 1 153M 19 S 1 
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155A 32 S 1 155A 34 S 1 
155M 32 S 1 155M 24 S 1 
156A 24 S 1 156A 18 S 1 
156M 18 I 1 156M 31 S 1 
157A 8 R 1 157A 36 S 1 
157M 15 R 1 157M 16 S 1 
158A 12 R 1 158A 24 S 1 
158B 22 S 1 158B 41 S 1 
158C 24 S 1 158C 38 S 1 
158M 34 S 1 158M 27 S 1 
161A 15 R 1 161A 42 S 1 
161M 27 S 1 161M 19 S 1 
162A 31 S 1 162A 33 S 1 
162M 20 S 1 162M 23 S 1 
169A 36 S 1 169A 33 S 1 
169M 32 S 1 169M 20 S 1 
170A 25 S 1 170A 41 S 1 
170B 38 S 1 170B 15 I 1 
170M 28 S 1 170M 18 S 1 
171A 36 S 1 171A 34 S 1 
171M 22 S 1 171M 25 S 1 
172A 23 S 1 172A 32 S 1 
172B 27 S 1 172B 25 S 1 
172C 33 S 1 172C 22 S 1 
172M 34 S 1 172M 18 S 1 
173A 18 I 1 173A 30 S 1 
173B 36 S 1 173B 21 S 1 
173M 8 R 1 173M 23 S 1 
176A 35 S 1 176A 29 S 1 
176M 33 S 1 176M 30 S 1 
180A 11 R 1 180A 37 S 1 
180M 48 S 1 180M 27 S 1 
181A 34 S 1 181A 30 S 1 
181M 31 S 1 181M 21 S 1 
182A 26 S 1 182A 15 I 1 
182B 0 R 1 182B 32 S 1 
182M 20 S 1 182M 35 S 1 
183A 31 S 1 183A 27 S 1 
183M 25 S 1 183M 24 S 1 
184A 32 S 1 184A 30 S 1 
184M 17 I 1 184M 24 S 1 
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185A 16 I 1 185A 27 S 1 
185B 31 S 1 185B 27 S 1 
185C 17 I 1 185C 28 S 1 
185M 13 R 1 185M 24 S 1 
186A 35 S 1 186A 31 S 1 
186M 13 R 1 147A 36 S 0 
147A 49 S 0 147B 44 S 0 
147B 41 S 0 147M 39 S 0 
147M 37 S 0 148A 43 S 0 
148A 36 S 0 148B 39 S 0 
148B 35 S 0 148M 38 S 0 
148M 39 S 0 159A 33 S 0 
159A 22 S 0 159M 27 S 0 
159M 34 S 0 160A 39 S 0 
160A 25 S 0 160M 23 S 0 
160M 24 S 0 164A 34 S 0 
164A 27 S 0 164B 24 S 0 
164B 37 S 0 164M 23 S 0 
164M 41 S 0 174A 37 S 0 
174A 25 S 0 174B 25 S 0 
174B 33 S 0 174C 34 S 0 
174C 34 S 0 174M 31 S 0 
174M 31 S 0 175A 30 S 0 
175A 12 R 0 175M 22 S 0 
175M 35 S 0 177A 28 S 0 
177A 0 R 0 177M 27 S 0 
177M 13 R 0 178A 38 S 0 
178A 23 S 0 178M 29 S 0 
178M 43 S 0 179A 30 S 0 
179A 38 S 0 179B 35 S 0 
179B 39 S 0 179C 39 S 0 
179C 25 S 0 179M 18 S 0 
179M 13 R 0     
Appendix V: Rifampin and Doxycycline ZOI organized by category 
 
Gram Positive 
Coccus 
Gram Positive 
Bacillus 
Gram Negative  
Bacillus 
Total 
253 104 20 377 
67.1% 27.6% 5.3% 100% 
Appendix W: Comprehensive Gram Staining Results 
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Student Participation Questionnaire and Authorization for Participation 
1. Have you been prescribed antibiotics in the last two years?        _______YES          
________ NO 
2. If yes, can you recall which antibiotic and the duration?  
 
       Have you ever taken antibiotics specifically for acne?  ______YES       _________NO 
 
3. During the course of antibiotic treatment, did you also use a topical face wash or 
gel? Did your dermatologist prescribe this treatment?  ________ YES     __________NO 
 
4.  Can you list the active ingredient found in your daily face wash?  
 
5. Has your acne improved? _________ YES  ___________ NO 
6. Which therapy or face wash has worked the best?  
 
7.   Briefly describe your skin. Do you break out often? Have you ever had acne?  
 
In today’s world, antibiotics are becoming more and more prevalent. This prevalence 
however, also leads to a development in antibiotic resistance. Persons battling acne are 
prescribed antibiotic regimens that may last for two months all the way up to a year. 
Recent studies suggest that antibiotic resistance can develop in as little as 12 weeks. 
Most acne patients are not rid of the condition prior to stopping antibiotic use, leaving 
colonies present that have now developed resistance to that specific antibiotic.  
Increased research on this subject may pave the way for improvement in treating acne.  
We will be collecting a sample of your skin cells using a non-evasive swabbing protocol. 
Three samples will be obtained with a cotton swab and tested for antibiotic resistance 
development as well as a survey of the bacteria present. This experiment will be 
conducted at Pittsburg State University and will not include any of your personal 
information, other than your signature for consent.. This research is completely 
voluntary and you may withdraw at any moment, but if you are giving consent to 
participate, please sign and date below.    
 
Signature ___________________________________________________         Date____________________________ 
Appendix X: Informed Consent. Each student completed and signed this form.  
